About the Company
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease. Chembio's products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CEMI News
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets
In Vitro Diagnostics Market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised to reach $119.4 billion by 2029, growing ...
HIV Rapid Testing Market Size Worth $6.3 Billion By 2030: IndustryARC
The Global HIV Rapid Testing Market size is predicted to reach $15.07 billion by 2030, growing at a CAGR of 7.22% during the forecast period 2024-2030 according to the latest market research report ...
Loading the latest forecasts...